FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2369908940> ?p ?o ?g. }

• W2369908940 endingPage "e3629" @default.
• W2369908940 startingPage "e3629" @default.
• W2369908940 abstract "There are a number of conflicting reports describing the clinical outcomes of using N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis. We have, therefore, performed a meta-analysis to evaluate the efficacy of N-acetylcysteine, compared with control, for the treatment of idiopathic pulmonary fibrosis. Original controlled clinical trials evaluating the efficacy of N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis were included in the analysis. Searches for relevant articles were carried out in July 2014 by 2 independent researchers using PubMed, Embase, Cochrane Central, and Google Scholar. Change in forced vital capacity, change in percentage of predicted vital capacity, change in percentage of predicted carbon monoxide diffusing capacity, changes in 6 minutes walking test distance, rate of adverse events, and rate of death were expressed as outcomes using RevMan 5.0.1. Five trials, with a total of 564 patients, were included in this meta-analysis. The meta-analysis showed that the control group had significant decreases in percentage of predicted vital capacity (standardized mean difference [SMD] = 0.37; 95% confidence interval [CI]: 0.13 to −0.62; P = 0.003) and 6 minutes walking test distance (SMD = 0.25; 95% CI: 0.02–0.48; P = 0.04). There were no statistically significant differences in forced vital capacity (SMD = 0.07; 95% CI: −0.13–0.27; P = 0.52), percentage of predicted carbon monoxide diffusing capacity (SMD = 0.12; 95% CI: −0.06–0.30; P = 0.18), rates of adverse events (odd ratio = 4.50; 95% CI: 0.19–106.41; P = 0.35), or death rates (odd ratio = 1.79; 95% CI: 0.3–5.12; P = 0.28) between the N-acetylcysteine group and the control group. N-Acetylcysteine was found to have a significant effect only on decreases in percentage of predicted vital capacity and 6 minutes walking test distance. N-acetylcysteine showed no beneficial effect on changes in forced vital capacity, changes in predicted carbon monoxide diffusing capacity, rates of adverse events, or death rates." @default.
• W2369908940 created "2016-06-24" @default.
• W2369908940 creator A5035282947 @default.
• W2369908940 creator A5038239024 @default.
• W2369908940 creator A5063224196 @default.
• W2369908940 date "2016-05-01" @default.
• W2369908940 modified "2023-10-17" @default.
• W2369908940 title "Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis" @default.
• W2369908940 cites W1569431722 @default.
• W2369908940 cites W1957975414 @default.
• W2369908940 cites W2009656648 @default.
• W2369908940 cites W2013280721 @default.
• W2369908940 cites W2022493223 @default.
• W2369908940 cites W2028922618 @default.
• W2369908940 cites W2039127564 @default.
• W2369908940 cites W2048179639 @default.
• W2369908940 cites W2057578683 @default.
• W2369908940 cites W2081449290 @default.
• W2369908940 cites W2093497326 @default.
• W2369908940 cites W2116348422 @default.
• W2369908940 cites W2118696428 @default.
• W2369908940 cites W2123700925 @default.
• W2369908940 cites W2125322938 @default.
• W2369908940 cites W2131944618 @default.
• W2369908940 cites W2136233703 @default.
• W2369908940 cites W2141874323 @default.
• W2369908940 cites W2143560353 @default.
• W2369908940 cites W2147690198 @default.
• W2369908940 cites W2149746349 @default.
• W2369908940 cites W2166267921 @default.
• W2369908940 cites W2167506008 @default.
• W2369908940 cites W2170100116 @default.
• W2369908940 cites W4296612182 @default.
• W2369908940 doi "https://doi.org/10.1097/md.0000000000003629" @default.
• W2369908940 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4902516" @default.
• W2369908940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27175674" @default.
• W2369908940 hasPublicationYear "2016" @default.
• W2369908940 type Work @default.
• W2369908940 sameAs 2369908940 @default.
• W2369908940 citedByCount "30" @default.
• W2369908940 countsByYear W23699089402016 @default.
• W2369908940 countsByYear W23699089402018 @default.
• W2369908940 countsByYear W23699089402019 @default.
• W2369908940 countsByYear W23699089402020 @default.
• W2369908940 countsByYear W23699089402021 @default.
• W2369908940 countsByYear W23699089402022 @default.
• W2369908940 countsByYear W23699089402023 @default.
• W2369908940 crossrefType "journal-article" @default.
• W2369908940 hasAuthorship W2369908940A5035282947 @default.
• W2369908940 hasAuthorship W2369908940A5038239024 @default.
• W2369908940 hasAuthorship W2369908940A5063224196 @default.
• W2369908940 hasBestOaLocation W23699089401 @default.
• W2369908940 hasConcept C126322002 @default.
• W2369908940 hasConcept C141071460 @default.
• W2369908940 hasConcept C165637977 @default.
• W2369908940 hasConcept C185592680 @default.
• W2369908940 hasConcept C197934379 @default.
• W2369908940 hasConcept C2776890885 @default.
• W2369908940 hasConcept C2777714996 @default.
• W2369908940 hasConcept C2777847592 @default.
• W2369908940 hasConcept C2778004101 @default.
• W2369908940 hasConcept C2778341716 @default.
• W2369908940 hasConcept C28804328 @default.
• W2369908940 hasConcept C3018587741 @default.
• W2369908940 hasConcept C44249647 @default.
• W2369908940 hasConcept C55493867 @default.
• W2369908940 hasConcept C55520419 @default.
• W2369908940 hasConcept C71924100 @default.
• W2369908940 hasConcept C95190672 @default.
• W2369908940 hasConceptScore W2369908940C126322002 @default.
• W2369908940 hasConceptScore W2369908940C141071460 @default.
• W2369908940 hasConceptScore W2369908940C165637977 @default.
• W2369908940 hasConceptScore W2369908940C185592680 @default.
• W2369908940 hasConceptScore W2369908940C197934379 @default.
• W2369908940 hasConceptScore W2369908940C2776890885 @default.
• W2369908940 hasConceptScore W2369908940C2777714996 @default.
• W2369908940 hasConceptScore W2369908940C2777847592 @default.
• W2369908940 hasConceptScore W2369908940C2778004101 @default.
• W2369908940 hasConceptScore W2369908940C2778341716 @default.
• W2369908940 hasConceptScore W2369908940C28804328 @default.
• W2369908940 hasConceptScore W2369908940C3018587741 @default.
• W2369908940 hasConceptScore W2369908940C44249647 @default.
• W2369908940 hasConceptScore W2369908940C55493867 @default.
• W2369908940 hasConceptScore W2369908940C55520419 @default.
• W2369908940 hasConceptScore W2369908940C71924100 @default.
• W2369908940 hasConceptScore W2369908940C95190672 @default.
• W2369908940 hasIssue "19" @default.
• W2369908940 hasLocation W23699089401 @default.
• W2369908940 hasLocation W23699089402 @default.
• W2369908940 hasLocation W23699089403 @default.
• W2369908940 hasOpenAccess W2369908940 @default.
• W2369908940 hasPrimaryLocation W23699089401 @default.
• W2369908940 hasRelatedWork W2027822748 @default.
• W2369908940 hasRelatedWork W2029532220 @default.
• W2369908940 hasRelatedWork W2191199355 @default.
• W2369908940 hasRelatedWork W2217826927 @default.
• W2369908940 hasRelatedWork W2369908940 @default.
• W2369908940 hasRelatedWork W2960124638 @default.

• next